FTC sues global medical group alleging deceptive promotion of child gender surgeries

• The Federal Trade Commission and four states sued WPATH on June 17, 2026, alleging false claims about pediatric gender transition procedures
• WPATH omitted minimum age requirements for breast amputation and penis removal from its 2022 standards without medical evidence
• The complaint alleges WPATH failed to disclose serious side effects including incontinence, infertility and permanent sexual dysfunction
• FTC officials claim WPATH members profited from misleading parents with “lifesaving” suicide prevention claims unsupported by scientific evidence
• The lawsuit represents a significant federal action against a medical organization for allegedly deceptive health claims affecting children

Federal regulators target transgender health association

The Federal Trade Commission, joined by four states, filed a federal lawsuit against the World Professional Association for Transgender Health on June 17, alleging the organization systematically misled parents about the safety and necessity of irreversible medical procedures for children as young as 12.

The complaint, filed in the U.S. District Court for the Northern District of Texas, alleges WPATH provided clinicians with guidance enabling false claims that puberty blockers, cross-sex hormones and surgical interventions were medically necessary and supported by scientific consensus. Authorities say the organization removed all age restrictions from its standards for breast removal and genital surgeries in 2022 without evidentiary basis.

Allegations of hidden risks and misrepresented benefits

The FTC complaint alleges WPATH failed to disclose documented side effects of pediatric transition interventions, including mood disturbances, vocal pain, pelvic pain, clitoral discomfort, vaginal pain, inability to orgasm, incontinence and erectile pain. The organization also promoted services as “lifesaving,” claiming they reduced suicide risk despite no competent scientific evidence supporting that assertion, according to regulators. In fact, in many cases, suicide risk goes up after these kinds of surgeries.

“Children, but especially their parents, must have complete and truthful information when making decisions to purchase medical services,” FTC Chairman Andrew Ferguson said in a statement. Texas Attorney General Ken Paxton said the organization would “face the full force of the law for harming children.”

Historical context: Shifting standards and medical oversight

The lawsuit emerges amid growing scrutiny of medical organizations that set treatment guidelines for vulnerable populations. WPATH’s Standards of Care have long been cited as authoritative by clinicians and insurance companies determining coverage. The FTC’s action marks a notable shift in federal enforcement, applying traditional consumer protection standards against a medical trade association.

This case echoes earlier federal interventions involving health claims, though regulatory agencies have historically focused on dietary supplements and pharmaceutical marketing. The FTC alleges WPATH violated the FTC Act by providing “the means for medical providers to make false and unsubstantiated claims to parents.”

State attorneys general join federal action

Nebraska Attorney General Mike Hilgers described WPATH as advancing “profit-driven ideology unsupported by science.” Iowa Attorney General Brenna Bird said recommendations were “based on politics and ideology” rather than medical evidence. Alaska Acting Attorney General Cori Mills emphasized that “irreversible treatments with lifelong consequences” demand transparency standards comparable to defective products or opioid marketing.

The four states joining the suit represent a coordinated multi-state enforcement effort. The commission voted 2-0 to authorize the complaint.

Broader implications for medical guidelines

The lawsuit raises fundamental questions about how medical organizations establish treatment standards for children. WPATH, whose members profit from the procedures it recommends, faces allegations that it prioritized financial interests over patient safety. The FTC complaint details instances where parents reported clinicians asking whether they would rather have “a live daughter or a dead son,” based on unsubstantiated claims about suicide prevention.

The case will proceed in federal court, where the court will determine whether WPATH’s guidelines constitute deceptive trade practices. The outcome could reshape how medical organizations develop and promote treatment protocols for minors nationwide.

Sources for this article include:

ChildrensHealthDefense.org

FTC.gov

Axios.com